XRTX · XORTX Therapeutics Inc. · Financials
Market Cap
$3.43M
Shares
1.82M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Net Income
-$2.66M
+19.8%
FY2025
Diluted EPS
-$2.80
+51.3%
FY2025
Operating Cash Flow
-$2.77M
+24.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| CAD | — | — | — | 75.27K | 17.88K | 20.44K | 19.9K |
| USD/shares | -$2.80 | -$5.75 | -$5.45 | -$26.10 | -$7.20 | — | — |
| USD/shares | -$2.80 | -$5.75 | -$5.45 | -$26.10 | -$7.20 | — | — |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.